🇺🇸 FDA
Patent

US 11028144

Soluble glycoprotein V for treating thrombotic diseases

granted A61KA61K38/177A61K38/38

Quick answer

US patent 11028144 (Soluble glycoprotein V for treating thrombotic diseases) held by Julius-Maximilians-Universitat Wurzburg expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/177, A61K38/38, A61K38/40, A61K45/06